photo of A/Prof David Elliott

A/Prof David Elliott

A/Prof David Elliott

Details

Role Group Leader / Principal Research Fellow
Research area Stem cell biology

Contact

Available for student supervision
Assoc. Prof. David Elliott leads the Heart Disease Group at the Murdoch Childrens Research Institute and he is a principal investigator of the Novo Nordisk Foundation for Stem Cell Medicine (reNEW). David co-directs, with Assoc. Prof. Rachel Conyers, the Australian Cardio-Oncology Registry (ACOR), a national program targeted at improving long-term cardiac health outcomes for childhood cancer survivors. The focus of Assoc. Prof. Elliott’s laboratory is to develop pluripotent stem cell-based models of heart disease and use these models to find new therapies for heart disease. Throughout his career Assoc. Prof. Elliott has made important contributions to understanding the molecular control of heart muscle development, function and disease.

Assoc. Prof. David Elliott completed his PhD on the genetics of heart development at The Victor Chang Cardiac Research Institute and The Walter and Eliza Hall Institute. He continued to post-doctoral studies at the University of Cambridge studying the nervous system in the fruit fly at the Wellcome Trust/Cancer Research UK Gurdon Institute. Assoc. Prof Elliott began using human pluripotent stem cells in a second post-doc with Profs. Andrew Elefanty and Ed Stanley at Monash University where he generated key stem cell lines and identified the first cardiac lineage cell surface markers.
Assoc. Prof. David Elliott leads the Heart Disease Group at the Murdoch Childrens Research Institute and he is a principal investigator of the Novo Nordisk Foundation for Stem Cell Medicine (reNEW). David co-directs, with Assoc. Prof. Rachel Conyers,...
Assoc. Prof. David Elliott leads the Heart Disease Group at the Murdoch Childrens Research Institute and he is a principal investigator of the Novo Nordisk Foundation for Stem Cell Medicine (reNEW). David co-directs, with Assoc. Prof. Rachel Conyers, the Australian Cardio-Oncology Registry (ACOR), a national program targeted at improving long-term cardiac health outcomes for childhood cancer survivors. The focus of Assoc. Prof. Elliott’s laboratory is to develop pluripotent stem cell-based models of heart disease and use these models to find new therapies for heart disease. Throughout his career Assoc. Prof. Elliott has made important contributions to understanding the molecular control of heart muscle development, function and disease.

Assoc. Prof. David Elliott completed his PhD on the genetics of heart development at The Victor Chang Cardiac Research Institute and The Walter and Eliza Hall Institute. He continued to post-doctoral studies at the University of Cambridge studying the nervous system in the fruit fly at the Wellcome Trust/Cancer Research UK Gurdon Institute. Assoc. Prof Elliott began using human pluripotent stem cells in a second post-doc with Profs. Andrew Elefanty and Ed Stanley at Monash University where he generated key stem cell lines and identified the first cardiac lineage cell surface markers.

Top Publications

  • McCafferty, C, Lee, L, Cai, T, Praporski, S, Stolper, J, Karlaftis, V, Attard, C, Myint, D, Carey, LM, Howells, DW, et al. Fibrin clot characteristics and anticoagulant response in a SARS‐CoV‐2‐infected endothelial model. eJHaem 3(2) : 326 -334 2022
    view publication
  • Park, S, Kim, H, Lee, S, Kim, J, Jung, T, Choi, SW, Park, B, Kang, S, Elliott, DA, Stanley, EG, et al. Effect and application of cryopreserved three‐dimensional microcardiac spheroids in myocardial infarction therapy. Clinical and Translational Medicine 12(1) : e721 2022
    view publication
  • Stout, ES, Elliott, DA, Porrello, ER. Towards a better understanding of cardiac fibrosis. The Journal of Cardiovascular Aging 2(3) : 24 2022
    view publication
  • Mohenska, M, Tan, NM, Tokolyi, A, Furtado, MB, Costa, MW, Perry, AJ, Hatwell-Humble, J, van Duijvenboden, K, Nim, HT, Ji, YMM, et al. 3D-cardiomics: A spatial transcriptional atlas of the mammalian heart. Journal of Molecular and Cellular Cardiology 163: 20 -32 2021
    view publication
  • McKnight, CL, Low, YC, Elliott, DA, Thorburn, DR, Frazier, AE. Modelling Mitochondrial Disease in Human Pluripotent Stem Cells: What Have We Learned?. International Journal of Molecular Sciences 22(14) : 7730 2021
    view publication

Page 1 of 19

Professional activities